Cite
HARVARD Citation
Wang-Gillam, A. et al. (2016). Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open-label, phase 3 trial. Lancet. 387 (10018), pp. 545-557. [Online].